Emerging studies suggest Retatrutide , a dual agonist targeting both the gut-brain axis and another hormone, could represent a promising development for weight management . Preliminary human tests have https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide